Cardiometabolic medication exposures and cognitive outcomes in Alzheimer's disease.

Wang Y, Goudey B, Masters CL, Jin L, Pan Y, Health and Aging Brain Study (HABS-HD) Study Team

Open source

DOI
10.1093/ageing/afag263
Published
2026 Sep 4
Container
Age and ageing
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ageing/afag263,
  title = {Cardiometabolic medication exposures and cognitive outcomes in Alzheimer's disease.},
  author = {Wang Y and Goudey B and Masters CL and Jin L and Pan Y and Health and Aging Brain Study (HABS-HD) Study Team},
  year = {2026},
  journal = {Age and ageing},
  doi = {10.1093/ageing/afag263},
  url = {https://doi.org/10.1093/ageing/afag263}
}

RIS

TY  - JOUR
TI  - Cardiometabolic medication exposures and cognitive outcomes in Alzheimer's disease.
AU  - Wang Y
AU  - Goudey B
AU  - Masters CL
AU  - Jin L
AU  - Pan Y
AU  - Health and Aging Brain Study (HABS-HD) Study Team
PY  - 2026
JO  - Age and ageing
DO  - 10.1093/ageing/afag263
UR  - https://doi.org/10.1093/ageing/afag263
ER  - 

APA

Y, W., B, G., CL, M., L, J., Y, P., & Team, H. A. A. B. S. (. S. (2026). Cardiometabolic medication exposures and cognitive outcomes in Alzheimer's disease.. Age and ageing. https://doi.org/10.1093/ageing/afag263

Source records